N-methyl-D-aspartate receptor clustering [BP],
regulation of grooming behavior [BP],
neuroligin clustering [BP],
gamma-aminobutyric acid receptor clustering [BP],
guanylate kinase-associated protein clustering [BP],
gephyrin clustering [BP],
neuroligin family protein binding [MF]
cellular response to interleukin-13 [BP],
positive regulation of Ran GTPase activity [BP],
Ran GTPase activator activity [MF],
sedoheptulokinase activity [MF]
very-long-chain-acyl-CoA dehydrogenase activity [MF],
sphingosine hydroxylase activity [MF],
sphingolipid delta-4 desaturase activity [MF]
Holliday junction resolvase complex [CC]
S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [MF]
zeta DNA polymerase complex [CC],
myosin light chain binding [MF]
positive regulation of neuron differentiation [BP],
positive regulation of type B pancreatic cell development [BP],
type B pancreatic cell maturation [BP]
endoderm development [BP]
histone deacetylase complex [CC],
embryonic forelimb morphogenesis [BP],
metanephric cap mesenchymal cell proliferation involved in metanephros development [BP],
specification of posterior mesonephric tubule identity [BP],
intermediate mesoderm development [BP],
renal vesicle progenitor cell differentiation [BP],
specification of anterior mesonephric tubule identity [BP],
posterior mesonephric tubule development [BP],
embryonic hindlimb morphogenesis [BP],
metanephric interstitial cell development [BP]
alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
UDP-N-acetylglucosamine catabolic process [BP]
negative regulation of endodermal cell fate specification [BP],
positive regulation of Notch signaling pathway involved in heart induction [BP],
endothelial cell differentiation [BP],
cardiac atrium formation [BP],
establishment or maintenance of polarity of embryonic epithelium [BP],
outer medullary collecting duct development [BP],
apolipoprotein A-I-mediated signaling pathway [BP],
cellular response to retinoic acid [BP],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
sinus venosus morphogenesis [BP],
smooth muscle cell differentiation [BP]
UDP-D-xylose biosynthetic process [BP],
UDP-glucuronate decarboxylase activity [MF],
tyrosyl-RNA phosphodiesterase activity [MF]
canalicular bile acid transmembrane transporter activity [MF],
bile acid-exporting ATPase activity [MF],
platelet alpha granule organization [BP],
vasodilation of artery involved in baroreceptor response to increased systemic arterial blood pressure [BP],
sodium-exporting ATPase activity, phosphorylative mechanism [MF]
peripheral nervous system development [BP],
methylglyoxal metabolic process [BP],
lactoylglutathione lyase activity [MF]
somatotropin secreting cell development [BP],
negative regulation of sequence-specific DNA binding transcription factor activity [BP],
regulation of interleukin-18 biosynthetic process [BP],
random inactivation of X chromosome [BP]
substance K receptor activity [MF]
glutathione synthase activity [MF],
response to tumor necrosis factor [BP],
benzaldehyde dehydrogenase activity [MF],
folic acid-containing compound biosynthetic process [BP],
all-trans retinal binding [MF],
cellular response to lipopolysaccharide [BP],
small molecule metabolic process [BP]
positive regulation of heart rate by epinephrine-norepinephrine [BP],
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [BP],
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [BP],
positive regulation of the force of heart contraction by epinephrine-norepinephrine [BP]
CTP salvage [BP],
positive regulation of DNA replication involved in S phase [BP],
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [BP],
UV-damage excision repair [BP]
fucosylgalactoside 3-alpha-galactosyltransferase activity [MF],
quinine 3-monooxygenase activity [MF],
deoxycytidyl transferase activity [MF],
albendazole monooxygenase activity [MF],
glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [MF],
taurochenodeoxycholate 6alpha-hydroxylase activity [MF],
error-prone translesion synthesis [BP]
negative regulation of extracellular matrix disassembly [BP],
regulation of myosin-light-chain-phosphatase activity [BP],
negative regulation of elastin catabolic process [BP],
negative regulation of histolysis [BP],
negative regulation of collagen catabolic process [BP],
18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF]
5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF],
5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF],
growth plate cartilage chondrocyte morphogenesis [BP]
dopamine neurotransmitter receptor activity, coupled via Gs [MF]
sphinganine biosynthetic process [BP]
somatostatin receptor binding [MF],
anterior semicircular canal development [BP],
lambdoid suture morphogenesis [BP],
habituation [BP],
lateral semicircular canal development [BP],
sagittal suture morphogenesis [BP],
lateral ganglionic eminence cell proliferation [BP]
sphingosine hydroxylase activity [MF],
negative regulation of metanephric nephron tubule epithelial cell differentiation [BP],
interleukin-2-mediated signaling pathway [BP],
interferon-gamma receptor binding [MF],
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [BP],
positive regulation of vitamin D biosynthetic process [BP],
CD8-positive, alpha-beta T cell differentiation involved in immune response [BP],
positive regulation of fructose 1,6-bisphosphate metabolic process [BP],
sphingolipid delta-4 desaturase activity [MF],
positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity [BP]
oxidative DNA demethylation [BP],
trans-2-enoyl-CoA reductase (NADPH) activity [MF],
DNA-N1-methyladenine dioxygenase activity [MF]
activation of JNKK activity [BP],
pyrimidine dimer repair [BP]
negative regulation of heat generation [BP],
spleen development [BP],
spleen trabecula formation [BP]
protein polyubiquitination [BP],
muscle tendon junction [CC],
negative regulation of protein deubiquitination [BP]
aromatic-L-amino-acid decarboxylase activity [MF],
interleukin-18 receptor complex [CC],
2-aminoadipate transaminase activity [MF]
phosphoethanolamine phosphatase activity [MF],
apelin receptor binding [MF],
sensory perception of pain [BP],
acetylcholine receptor activator activity [MF]
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [BP],
alpha1-adrenergic receptor activity [MF]
mitotic prophase [BP],
response to anoxia [BP]
histone H3-K27 methylation [BP]
hormone-sensitive lipase activity [MF],
diacylglycerol catabolic process [BP]
erythrophore differentiation [BP],
protein tyrosine phosphatase activity [MF],
age-dependent response to reactive oxygen species [BP],
response to silicon dioxide [BP]
visceral serous pericardium development [BP],
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP],
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP]
bud elongation involved in lung branching [BP],
mesenchymal cell differentiation involved in lung development [BP],
lacrimal gland development [BP],
fibroblast growth factor receptor signaling pathway involved in mammary gland specification [BP],
orbitofrontal cortex development [BP],
protein tyrosine kinase activity [MF],
endodermal digestive tract morphogenesis [BP],
epidermal growth factor-activated receptor activity [MF],
peptidyl-tyrosine phosphorylation [BP],
branch elongation involved in salivary gland morphogenesis [BP],
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP],
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [BP],
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP],
fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP],
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [BP],
coronal suture morphogenesis [BP],
mesenchymal cell proliferation involved in lung development [BP],
positive regulation of rhodopsin gene expression [BP],
prostate epithelial cord elongation [BP],
visual perception [BP],
ventricular zone neuroblast division [BP],
regulation of rhodopsin gene expression [BP]
evasion or tolerance by virus of host immune response [BP],
phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [MF],
phosphatidyl-N-methylethanolamine N-methyltransferase activity [MF]
chemokine (C-C motif) ligand 5 binding [MF],
chemokine (C-C motif) ligand 7 binding [MF]
methotrexate transport [BP],
methotrexate transporter activity [MF]
response to ethanol [BP]
3'(2'),5'-bisphosphate nucleotidase activity [MF],
3'-nucleotidase activity [MF]
cerebellar cortex development [BP],
acetylcholine receptor activator activity [MF]
protein kinase C-activating G-protein coupled receptor signaling pathway [BP]
GPI anchor release [BP],
cellular response to triglyceride [BP],
positive regulation of high-density lipoprotein particle clearance [BP],
glycosylphosphatidylinositol phospholipase D activity [MF],
small molecule metabolic process [BP],
hematopoietic stem cell migration to bone marrow [BP]
visceral serous pericardium development [BP],
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP],
histone demethylase activity (H3-trimethyl-K4 specific) [MF],
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP]
cardiolipin binding [MF],
positive regulation of mitochondrial DNA replication [BP],
positive regulation of cardiolipin metabolic process [BP]
calcium ion-dependent exocytosis of neurotransmitter [BP],
positive regulation of calcium ion-dependent exocytosis [BP]
positive regulation of cytoplasmic translation [BP]
lysosome localization [BP],
endosome localization [BP]
regulation of pronephros size [BP]
phosphatidylcholine metabolic process [BP],
alpha-(1->3)-fucosyltransferase activity [MF],
Golgi cisterna membrane [CC],
double-stranded methylated DNA binding [MF],
fucosyltransferase activity [MF],
3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [MF]
asparagine synthase (glutamine-hydrolyzing) activity [MF],
peptide:hydrogen symporter activity [MF],
proton-dependent oligopeptide secondary active transmembrane transporter activity [MF],
L-asparagine biosynthetic process [BP],
supercoiled DNA binding [MF],
asparagine biosynthetic process [BP],
release from viral latency [BP],
response to methotrexate [BP],
positive regulation of cell cycle [BP]
tRNA (uracil) methyltransferase activity [MF]
cellular response to amine stimulus [BP],
MHC class Ib protein binding [MF],
uroporphyrinogen-III synthase activity [MF]
response to interleukin-2 [BP],
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [BP],
response to interleukin-11 [BP],
LBD domain binding [MF]
phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [MF]
dynein light chain binding [MF],
negative regulation of arachidonic acid secretion [BP],
corticosterone 18-monooxygenase activity [MF],
negative regulation of phospholipase A2 activity [BP]
thymine binding [MF],
chiasma [CC],
uracil binding [MF],
uracil catabolic process [BP],
thymine catabolic process [BP],
MutLbeta complex [CC]
transferrin receptor activity [MF]
adenylate cyclase inhibiting G-protein coupled glutamate receptor activity [MF]
artery morphogenesis [BP],
snRNA import into nucleus [BP],
acyl-CoA ligase activity [MF],
benzoate metabolic process [BP]
endoplasmic reticulum membrane fusion [BP],
multinuclear osteoclast differentiation [BP],
Golgi reassembly [BP]
diadenosine polyphosphate catabolic process [BP],
sulfotransferase activity [MF]
thyroid hormone mediated signaling pathway [BP],
FMN binding [MF]
positive regulation of fibroblast proliferation [BP],
ornithine-oxo-acid transaminase activity [MF],
amidophosphoribosyltransferase activity [MF],
organ regeneration [BP],
U12-type spliceosomal complex [CC]
negative regulation of adenosine receptor signaling pathway [BP],
negative regulation of penile erection [BP],
dATP catabolic process [BP],
germinal center B cell differentiation [BP],
negative regulation of circadian sleep/wake cycle, non-REM sleep [BP],
xanthine biosynthetic process [BP],
deoxyadenosine catabolic process [BP]
CCR4-NOT complex [CC],
poly(G) RNA binding [MF],
viral envelope [CC]
U5 snRNP [CC]
positive regulation of ATP biosynthetic process [BP],
protein localization to plasma membrane [BP],
positive regulation of fat cell proliferation [BP],
negative regulation of ATP biosynthetic process [BP]
interleukin-23-mediated signaling pathway [BP],
interleukin-23 binding [MF],
interleukin-12 receptor complex [CC],
interleukin-12-mediated signaling pathway [BP],
interleukin-12 receptor activity [MF],
alpha-ketoglutarate transport [BP],
interleukin-23 receptor activity [MF],
oxoglutarate:malate antiporter activity [MF]
brain development [BP],
negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP],
aspartyl-tRNA aminoacylation [BP]
transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP],
neural fold formation [BP],
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP],
axial mesodermal cell fate specification [BP],
inhibition of neuroepithelial cell differentiation [BP]
borate transport [BP],
phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
structural constituent of bone [MF],
borate transmembrane transport [BP]
lactase activity [MF],
cysteine desulfurase activity [MF]
lactosylceramide alpha-2,3-sialyltransferase activity [MF]
beta-mannosidase activity [MF],
interleukin-12 alpha subunit binding [MF]
cholesterol monooxygenase (side-chain-cleaving) activity [MF],
response to genistein [BP]
endochitinase activity [MF]
negative regulation of interleukin-1 beta secretion [BP],
negative regulation of cell adhesion molecule production [BP]
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF],
positive regulation vascular endothelial growth factor production [BP],
positive regulation of endothelial cell migration [BP],
transaminase activity [MF],
positive regulation of platelet-derived growth factor production [BP],
kynurenine-glyoxylate transaminase activity [MF],
2-oxoglutarate metabolic process [BP],
pyridoxal phosphate binding [MF],
maintenance of blood-brain barrier [BP],
aromatic amino acid family metabolic process [BP],
protein homodimerization activity [MF],
positive regulation of fibroblast growth factor production [BP]
endosome localization [BP]
collagen metabolic process [BP],
positive regulation of cortisol biosynthetic process [BP],
negative regulation of testicular blood vessel morphogenesis [BP],
negative regulation of male gonad development [BP]
(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity [MF],
5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF],
5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF]
vacuolar proton-transporting V-type ATPase complex assembly [BP],
NADH oxidation [BP]
sterol 12-alpha-hydroxylase activity [MF]
adenine binding [MF],
adenine salvage [BP],
antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP],
adenine phosphoribosyltransferase activity [MF]
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [MF],
histone serine kinase activity [MF],
[acetyl-CoA carboxylase] kinase activity [MF],
cold acclimation [BP],
negative regulation of glucosylceramide biosynthetic process [BP]
gamma-aminobutyric acid receptor clustering [BP],
neuroligin family protein binding [MF],
UDP-xylose transmembrane transporter activity [MF],
UDP-xylose transport [BP],
chylomicron remnant [CC],
guanylate kinase-associated protein clustering [BP]
voluntary musculoskeletal movement [BP],
retinal blood vessel morphogenesis [BP]
medium-chain-(S)-2-hydroxy-acid oxidase activity [MF],
(S)-2-hydroxy-acid oxidase activity [MF],
very-long-chain-(S)-2-hydroxy-acid oxidase activity [MF],
glycolate catabolic process [BP],
glycolate oxidase activity [MF],
glyoxylate oxidase activity [MF]
histone H2A-K15 ubiquitination [BP],
histone H2A-K13 ubiquitination [BP]
diplotene [BP]
(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [MF],
activating transcription factor binding [MF],
evasion or tolerance by virus of host immune response [BP],
negative regulation of histone H3-K27 acetylation [BP]
isoleucine catabolic process [BP],
L-leucine transaminase activity [MF],
branched-chain-amino-acid transaminase activity [MF],
L-isoleucine transaminase activity [MF],
branched-chain amino acid biosynthetic process [BP],
L-valine transaminase activity [MF]
intermediate filament [CC]
negative regulation of stem cell proliferation [BP],
desmosome disassembly [BP],
negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter [BP]
synaptic vesicle amine transport [BP],
neutrophil mediated killing of gram-positive bacterium [BP],
phytoalexin metabolic process [BP]
negative regulation of phosphatidylinositol biosynthetic process [BP],
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [BP],
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP],
transforming growth factor beta receptor signaling pathway [BP]
ciliary receptor clustering involved in smoothened signaling pathway [BP]
deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF]
UDP-xylose transport [BP],
UDP-N-acetylglucosamine transport [BP],
UDP-xylose transmembrane transporter activity [MF]
positive regulation of platelet-derived growth factor receptor signaling pathway [BP],
melanin biosynthetic process from tyrosine [BP],
activation of blood coagulation via clotting cascade [BP],
cell proliferation in forebrain [BP],
dopachrome isomerase activity [MF]
anterior/posterior axis specification [BP],
response to fatty acid [BP],
apical lamina of hyaline layer [CC]
sperm mitochondrial sheath [CC],
histone methylation [BP]